Anne Finucane - CVS Health Independent Director

CVS Stock  USD 79.76  0.33  0.42%   

Director

Ms. Anne M. Finucane is Independent Director of Cvs Caremark Corporationration Ms. Finucane was Vice Chairman of Bank of America Corporationrationration, an international financial services company, since July 2015 and is a member of its executive management team. From 2006 through July 2015 Ms. Finucane served as Global Chief Strategy and Marketing Officer for Bank of America and served as Northeast Market President from 2004 through July 2015. During her twentyplus years as a senior leader at Bank of America and its legacy firms, Ms. Finucane has served as senior advisor to four chief executive officers and the Board of Directors since 2011.
Age 68
Tenure 13 years
Address One CVS Drive, Woonsocket, RI, United States, 02895
Phone401 765 1500
Webhttps://www.cvshealth.com
Finucane is responsible for the strategic positioning of Bank of America and oversees the public policy, customer research and analytics, global marketing, communications and corporate social responsibility efforts for the company. She is chair of Bank of America’s Environmental, Social and Governance Committee, and is also chair of the Bank of America Charitable Foundation. B.A., University of New Hampshire.

CVS Health Management Efficiency

The company has Return on Asset of 0.0368 % which means that on every $100 spent on assets, it made $0.0368 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1128 %, implying that it generated $0.1128 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, CVS Health's Asset Turnover is comparatively stable compared to the past year.
The company has 79.39 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist CVS Health until it has trouble settling it off, either with new capital or with free cash flow. So, CVS Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CVS Health Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVS to invest in growth at high rates of return. When we think about CVS Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Jeremy StarkweatherMedigus Ltd ADR
42
Martha MarshEdwards Lifesciences Corp
72
Aviel ShapiraMedigus Ltd ADR
61
Yuval YanaiMedigus Ltd ADR
65
Prattipati LaxminarainMicrobot Medical
59
Ori HershkovitzMedigus Ltd ADR
39
Steven LorangerEdwards Lifesciences Corp
69
Eitan MachoverMedigus Ltd ADR
55
Oded YatzkanMedigus Ltd ADR
49
Ramona SequeiraEdwards Lifesciences Corp
55
William LinkEdwards Lifesciences Corp
Erez HaimovitzMedigus Ltd ADR
N/A
Solomon MayerMicrobot Medical
62
Barbara McNeilEdwards Lifesciences Corp
74
Martin MaddenMicrobot Medical
57
John CardisEdwards Lifesciences Corp
73
Anat NaschitzMedigus Ltd ADR
N/A
Wesley SchackEdwards Lifesciences Corp
74
Scott BurellMicrobot Medical
52
Kieran GallahueEdwards Lifesciences Corp
57
Yair RabinovitchMedigus Ltd ADR
67
CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. CVS Health Corp (CVS) is traded on New York Stock Exchange in USA. It is located in One CVS Drive, Woonsocket, RI, United States, 02895 and employs 219,000 people. CVS Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

CVS Health Corp Leadership Team

Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
J Joyner, Executive Vice President
Shawn Guertin, Chief Financial Officer, Executive Vice President
Richard Bracken, Independent Director
Mary Schapiro, Independent Director
Laurence McGrath, Senior Relations
Norman Greve, Chief Officer
David Brown, Independent Director
William Weldon, Independent Director
Kevin Hourican, Executive Vice President, President of CVS Pharmacy
Larry McGrath, Sr Relations
Stephen Gold, Senior Vice President CIO
Joshua Flum, Executive Vice President, Chief Strategy and Business Development Officer
Troyen Brennan, Executive Vice President Chief Medical Officer
Prem Shah, Executive Vice President, Chief Pharmacy Officer and Co-President of Retail
Karen Lynch, President, Chief Executive Officer, Director
Thomas Moriarty, Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Per Lofberg, Executive Vice President
David Joyner, Executive Vice President
David Falkowski, Executive Officer
Prem PharmD, Chief VP
Jonathan Roberts, Chief Operating Officer, Executive Vice President
Alan Lotvin, Executive Vice President and Presidentident - CVS Caremark
Neela Montgomery, Executive Vice President and President - CVS Pharmacy/Retail
Alan MD, Ex Services
Andrew Sussman, Senior Vice President Associate Chief Medical Officer
Robert Kraft, Executive Vice President
Edward Ludwig, Independent Director
David Dorman, Independent Chairman of the Board
Richard Swift, Independent Director
Fernando Aguirre, Independent Director
Laurie Havanec, Chief People Officer, Executive Vice President
C Brown, Independent Director
NancyAnn DeParle, Independent Director
David CEBS, Executive Caremark
Tilak Mandadi, Data, Digital
Thomas Cowhey, Executive CFO
JeanPierre Millon, Independent Director
Mark Bertolini, Independent Director
Alecia DeCoudreaux, Independent Director
Samrat Esq, Chief VP
Lisa Bisaccia, Chief Human Resource Officer, Executive Vice President
David Denton, CFO and Executive VP
Helena Foulkes, Executive VP and President of CVS Pharmacy Inc
Tony White, Independent Director
Anne Finucane, Independent Director
Vijay Patel, Senior CoFounder
Derica Rice, Executive Vice President, President of CVS Caremark
James Clark, Senior Vice President - Controller, Chief Accounting Officer
Eva Boratto, Chief Financial Officer, Executive Vice President
Daniel Finke, Executive Vice President and Presidentident - Health Care Benefits Segment
Larry Merlo, President, Chief Executive Officer, Director
Roger Farah, Independent Director
Michelle Peluso, Executive Vice President, Chief Customer Officer and Co-President of Retail

CVS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CVS Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.

Moving against CVS Stock

  0.43MBIO Mustang Bio Report 3rd of April 2024 PairCorr
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for CVS Stock analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.10)
Dividend Share
2.42
Earnings Share
6.47
Revenue Per Share
277.528
Quarterly Revenue Growth
0.12
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.